GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
cicirculating vaccine-derived poliovirus confirmed in Ukraine
…emergency outbreak response planned Two cases of circulating vaccine-derived poliovirus type 1 (cVDPV1) have been confirmed in Ukraine, the Global Polio Eradication Initiative (GPEI) has reported. The genetic similarity between
Killer in your fridge!
… Aspartame is sweet poison By Ifeoma Okoye In October of 2001, my sister started getting very sick She had stomach spasms and she was having a hard time getting
Lassa fever: Benue records 46 cases, 9 deaths
as FG announces plans for national de-ratisation campaign Benue State has reportedly recorded 46 Lassa Fever cases and nine deaths in seven Local Government Areas, LGAs, of the state. Some of
0 Comments
No Comments Yet!
You can be first to comment this post!